Mira Gleisberg

CEO & Co-founder at RespiQ

Mira Gleisberg has a diverse work experience spanning from 2004 to the present. Mira started their career as a Junior Associate at McKinsey & Company. Mira then worked as a Manager of Strategy at Numico before joining Spotzer as a CFO. Later, Gleisberg co-founded The Upside Club and worked as its Co-founder. Mira also took on the role of AMS project at THNK School of Creative Leadership. In 2015, they joined Philips where they held two positions: Head of Product Management and Head of Behavioral Change Innovation for Personal Health Solutions. In 2011, Gleisberg started their own company called Mira Consulting, where they worked as a Health Entrepreneur & Strategy Consultant. Their current role is CEO & Co-founder at RespiQ, a Dutch start-up focused on developing AI-enhanced breath analysis sensors for disease diagnosis and management. Overall, Gleisberg's work experience reflects their expertise in healthcare, digital innovation, strategy consulting, and entrepreneurship.

Mira Gleisberg's education history includes multiple qualifications and areas of study. In 1995-2000, they pursued a Master of Science degree in Human Biology at Leiden University. Following this, from 2000-2003, they obtained a Master's degree in Computer Science with a focus on Mediatechnology, also from Leiden University. In 2004, they participated in the McKinsey Training Program, completing a mini MBA. In 2013-2014, Mira attended THNK School of Leadership for a course in Leadership and Entrepreneurship. In 2018-2019, they furthered their education in Global eHealth at the University of Edinburgh. Additionally, during the same period, they engaged in Co-Active Coaching studies through SUAS - A Schouten & Nelissen Company.

Location

Amsterdam, Netherlands

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


RespiQ

RespiQ empowers people to take control of their health with validated (dietary) guidance they can trust. RespiQ is developing a cutting edge, patent pending technology based on proven science. After individualised breath-print analysis, customers receive personalized diet and health insights via an intuitive app.Because respiQ’s technology cancost effectively detect all relevant biomarkers, they are more accurate than direct competitors and therefore better enabled to improve people’s wellbeing.The team has the perfect combination of technical and healthcare expertise to enable people to live happier healthier lives by just breathing. We are excited to see the growth of RespiQ and their journey for enabling millions to get better health advice. - Kim Oreskovic, Partner, Antler Amsterdam


Industries

Employees

1-10

Links